Nucleic Acids in Human Glioma Treatment:  Innovative Approaches and Recent Results

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Delivery system</td><td align="center">siRNA target</td><td align="center">Ref.</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Pegylated immunoliposomes</td><td align="center">EGFR</td><td align="center"> [<a href="/journals/jst/2012/735135/#B29">29</a>]</td></tr><tr><td align="left">siRNA/TfR antibody complexes by biotin-streptavidin bridge</td><td align="center">Luciferase</td><td align="center">[<a href="/journals/jst/2012/735135/#B65">65</a>]</td></tr><tr><td align="left">Polyethylenimine/siRNA complexes</td><td align="center">Pleiotrophin</td><td align="center">[<a href="/journals/jst/2012/735135/#B66">66</a>]</td></tr><tr><td align="left">Nanoparticles/siRNA complexes</td><td align="center">HIF-1<i>α</i></td><td align="center">[<a href="/journals/jst/2012/735135/#B68">68</a>]</td></tr><tr><td align="left">Recombinant adeno-associated virus</td><td align="center">Hec1</td><td align="center">[<a href="/journals/jst/2012/735135/#B69">69</a>]</td></tr><tr><td align="left">Herpes simplex virus 1</td><td align="center">EGFR; Rad51</td><td align="center">[<a href="/journals/jst/2012/735135/#B70">70</a>, <a href="/journals/jst/2012/735135/#B71">71</a>]</td></tr><tr><td align="left">Lentiviral vectors</td><td align="center">shBcl-2 and S-TRAIL</td><td align="center">[<a href="/journals/jst/2012/735135/#B73">73</a>]</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Strategies for siRNA delivery across the BBB.

Journal of Signal Transduction

tab3

Table 3

Table 3: Nucleic Acids in Human Glioma Treatment:  Innovative Approaches and Recent Results 